The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Atrial Fibrillation and Diabetes Mellitus
Open accessAbstract
Diabetes mellitus is one of the most common chronic medical conditions, and is a risk factor for the development of atrial fibrillation (AF). The presence of diabetes in patients with AF is associated with increased symptom burden and increased cardiovascular and cerebrovascular mortality. The pathophysiology of diabetes-related AF is not fully understood, but is related to structural, electrical, electromechanical, and autonomic remodeling. This paper reviews the complex interaction between diabetes and AF, and explores its effect on the prevention and treatment of AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812389 · Cited by 6,382
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
Scirica, B. M., Bhatt, D. L., Braunwald, E., Steg, P. G., Davidson, J., Hirshberg, B., Ohman, P., Frederich, R., Wiviott, S. D., Hoffman, E. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1307684 · Cited by 3,470
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.-P., & Colette, C. (2006) · JAMA · doi:10.1001/jama.295.14.1681 · Cited by 2,444
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Holman, R. R., Bethel, M. A., Mentz, R. J., Thompson, V. P., Lokhnygina, Y., Buse, J. B., Chan, J. C., Choi, J., Gustavson, S. M., Iqbal, N., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612917 · Cited by 2,162
Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32261-x · Cited by 1,829
Self-citationBasal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Colilla, S., Crow, A., Petkun, W., Singer, D. E., Simon, T., & Liu, X. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.05.063 · Cited by 1,321
Rosenstock, J., Perkovic, V., Johansen, O. E., Cooper, M. E., Kahn, S. E., Marx, N., Alexander, J. H., Pencina, M., Toto, R. D., Wanner, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.18269 · Cited by 1,084
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Jia, G., Whaley-Connell, A., & Sowers, J. R. (2018) · Diabetologia · doi:10.1007/s00125-017-4390-4 · Cited by 868
Inflammation in Atrial Fibrillation
Guo, Y., Lip, G. Y. H., & Apostolakis, S. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.063 · Cited by 863
Huxley, R. R., Filion, K. B., Konety, S., & Alonso, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.004 · Cited by 561
Russo, I., & Frangogiannis, N. G. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.011 · Cited by 474
Anderson, E. J., Kypson, A. P., Rodriguez, E., Anderson, C. A., Lehr, E. J., & Neufer, P. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.031 · Cited by 440
Heart rate variability in type 2 diabetes mellitus: A systematic review and meta–analysis
Benichou, T., Pereira, B., Mermillod, M., Tauveron, I., Pfabigan, D., Maqdasy, S., & Dutheil, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0195166 · Cited by 419
Diabetes mellitus, glycemic control, and risk of atrial fibrillation
Dublin, S., Glazer, N. L., Smith, N. L., Psaty, B. M., Lumley, T., Wiggins, K. L., Page, R. L., & Heckbert, S. R. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1340-y · Cited by 310
Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential
Faria, A., & Persaud, S. J. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.013 · Cited by 295
Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp055 · Cited by 239
Chang, S.-H., Wu, L.-S., Chiou, M.-J., Liu, J.-R., Yu, K.-H., Kuo, C.-F., Wen, M.-S., Chen, W.-J., Yeh, Y.-H., & See, L.-C. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0123-x · Cited by 225
From Selective Parasympathetic Modulation of AV Node to Rate Control Therapy
BILLETTE, J., & LAVALLÉE, M. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.00271.x · Cited by 222
Long‐Term Outcome of Atrial Fibrillation Ablation: Impact and Predictors of Very Late Recurrence
WOKHLU, A., HODGE, D. O., MONAHAN, K. H., ASIRVATHAM, S. J., FRIEDMAN, P. A., MUNGER, T. M., CHA, Y., SHEN, W., BRADY, P. A., BLUHM, C. M., et al. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01786.x · Cited by 190
Cardiovascular autonomic neuropathies as complications of diabetes mellitus
Kuehl, M., & Stevens, M. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.21 · Cited by 181
Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes
Echouffo-Tcheugui, J. B., Shrader, P., Thomas, L., Gersh, B. J., Kowey, P. R., Mahaffey, K. W., Singer, D. E., Hylek, E. M., Go, A. S., Peterson, E. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.755 · Cited by 180
Self-citationFatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.045 · Cited by 173
FORLEO, G. B., MANTICA, M., DE LUCA, L., LEO, R., SANTINI, L., PANIGADA, S., DE SANCTIS, V., PAPPALARDO, A., LAURENZI, F., AVELLA, A., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01275.x · Cited by 165
Usman, M. S., Siddiqi, T. J., Memon, M. M., Khan, M. S., Rawasia, W. F., Talha Ayub, M., Sreenivasan, J., & Golzar, Y. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318755531 · Cited by 160
Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation
de Vos, C. B., Weijs, B., Crijns, H. J. G. M., Cheriex, E. C., Palmans, A., Habets, J., Prins, M. H., Pisters, R., Nieuwlaat, R., & Tieleman, R. G. (2008) · Heart · doi:10.1136/hrt.2008.148528 · Cited by 159
Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats
Saito, S., Teshima, Y., Fukui, A., Kondo, H., Nishio, S., Nakagawa, M., Saikawa, T., & Takahashi, N. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu176 · Cited by 149
AGEs‐RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat
Kato, T., Yamashita, T., SEKIGUCHI, A., Tsuneda, T., Sagara, K., Takamura, M., Kaneko, S., Aizawa, T., & Fu, L.-T. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01037.x · Cited by 147
Chao, T., Suenari, K., Chang, S., Lin, Y., Lo, L., Hu, Y., Tuan, T., TAI, C., Tsao, H.-M., Li, C.-H., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.07.038 · Cited by 135
VEGLIO, M., BRUNO, G., BORRA, M., MACCHIA, G., BARGERO, G., D'ERRICO, N., PAGANO, G. F., & CAVALLO‐PERIN, P. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00955.x · Cited by 132
Patti, G., Cavallari, I., Andreotti, F., Calabrò, P., Cirillo, P. L., Denas, G., Galli, M., Golia, E., Maddaloni, E., Marcucci, R., et al. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0080-2 · Cited by 128
Conduction and refractory disorders in the diabetic atrium
Watanabe, M., Yokoshiki, H., Mitsuyama, H., Mizukami, K., Ono, T., & Tsutsui, H. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00010.2012 · Cited by 126
Hypoglycemia and Cardiovascular Risk: Is There a Major Link?
Hanefeld, M., Frier, B. M., & Pistrosch, F. (2016) · Diabetes Care · doi:10.2337/dcs15-3014 · Cited by 124
Otake, H., Suzuki, H., Honda, T., & Maruyama, Y. (2009) · International Heart Journal · doi:10.1536/ihj.50.627 · Cited by 121
Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients
Ashburner, J. M., Go, A. S., Chang, Y., Fang, M. C., Fredman, L., Applebaum, K. M., & Singer, D. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.080 · Cited by 105
Chao, T., Leu, H., Huang, C., Chen, J., Chan, W., Lin, S., & Chen, S.-A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.081 · Cited by 104
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
Newman, J. D., Vani, A. K., Alemán, J. O., WEINTRAUB, H. S., Berger, J. S., & Schwartzbard, A. Z. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.071 · Cited by 103
Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis
Zhang, Z., Zhang, X., Korantzopoulos, P. G., Letsas, Κ. P., Tse, G., Gong, M., Meng, L., Li, G., & Liu, T. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0531-4 · Cited by 102
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes
Rizzo, M. R., Sasso, F. C., Marfella, R., Siniscalchi, M., Paolisso, P., Carbonara, O., Capoluongo, M. C., Lascar, N., Pace, C., Sardu, C., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.09.002 · Cited by 100
Kume, O., Takahashi, N., Wakisaka, O., Torigoe, Y., Teshima, Y., Nakagawa, M., Yufu, K., Hara, M., Saikawa, T., & Yoshimatsu, H. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.10.029 · Cited by 89
Anselmino, M., Matta, M., D'ascenzo, F., Pappone, C., Santinelli, V., Bunch, T. J., Neumann, T., Schilling, R. J., Hunter, R. J., Noelker, G., et al. (2015) · Europace · doi:10.1093/europace/euv214 · Cited by 88
Patti, G., Lucerna, M., Cavallari, I., Ricottini, E., Renda, G., Pecen, L., Romeo, F., Heuzey, J. L., Zamorano, J. L., Kirchhof, P. F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.069 · Cited by 84
Tiwari, S., Schirmer, H., Jacobsen, B. K., Hopstock, L. A., Nyrnes, A., Heggelund, G., Njølstad, I., Mathiesen, E. B., & Løchen, M. (2015) · Heart · doi:10.1136/heartjnl-2015-307438 · Cited by 81
Chang, C., Yeh, Y., Chan, Y., Liu, J., Chang, S., Lee, H., Wu, L., Yen, K., Kuo, C.-T., & See, L. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0640-5 · Cited by 81
Liu, C., Fu, H., Li, J., Yang, W., Cheng, L., Liu, T., & Li, G. (2012) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2012.188 · Cited by 77
Liou, Y.-S., Yang, F.-Y., Chen, H.-Y., & Jong, G.-P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197245 · Cited by 75
Qi, W., Zhang, N., Korantzopoulos, P. G., Letsas, Κ. P., Cheng, M., Di, F., Tse, G., Liu, T., & Li, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170955 · Cited by 75
Monami, M., Nreu, B., Scatena, A., Giannini, S., Andreozzi, F., Sesti, G., & Mannucci, E. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0698-7 · Cited by 74
Ko, S., Park, Y., Yun, J., Cha, S., Choi, E., Han, K., Han, E., Lee, Y., & Ahn, Y. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.09.009 · Cited by 68
Nelson, W. W., Choi, J. C., Vanderpoel, J., Damaraju, C. V., Wildgoose, P., Fields, L. E., & Schein, J. R. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.04.013 · Cited by 59
Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
Yu, O. H. Y., Azoulay, L., Yin, H., Filion, K. B., & Suissa, S. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.09.044 · Cited by 55
Lin, K. J., Cho, S. I., Tiwari, N., Bergman, M., Kizer, J. R., Palma, E., & Taub, C. C. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9863-x · Cited by 54
Can We Predict the Failure of Electrical Cardioversion of Acute Atrial Fibrillation? The FinCV Study
Grönberg, T., Hartikainen, J., Nuotio, I. O., Biancari, F., Vasankari, T., Nikkinen, M., Ylitalo, A., & Airaksinen, J. K. E. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12561 · Cited by 53
Demır, K., Avcı, A., Kaya, Z., Marakoğlu, K., Ceylan, E., Yilmaz, A., Erseçgin, A., Armutlukuyu, M., & Altunkeser, B. B. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.06.003 · Cited by 47
Defining the Role of Oxidative Stress in Atrial Fibrillation and Diabetes
Ziolo, M. T., & Mohler, P. J. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12560 · Cited by 44
Fu, H., Liu, C., Li, J., Zhou, C., Cheng, L., Liu, T., & Li, G. (2013) · Cardiology Journal · doi:10.5603/cj.2013.0010 · Cited by 42
Antihyperglycemic drugs use and new‐onset atrial fibrillation in elderly patients
Chen, H., Yang, F., Jong, G., & Liou, Y. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12754 · Cited by 42
Tang, R. B., Dong, J., Liu, X. P., Fang, D. P., Long, D., Liu, X., Yu, R. H., Hu, F. L., Lu, C. S., Hao, P., et al. (2007) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-006-9049-x · Cited by 38
Gu, J., Fan, Y., Zhang, J. F., & Wang, C. Q. (2017) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2017.7938 · Cited by 37
Ebert, M., Stegmann, C., Kosiuk, J., Dinov, B., Richter, S., Arya, A., Müssigbrodt, A., Sommer, P., Hindricks, G., & Bollmann, A. (2017) · EP Europace · doi:10.1093/europace/eux327 · Cited by 35
Lee, H., Choi, E., Han, K., Kim, D. H., Lee, E., Lee, S., Oh, S., & Lip, G. Y. H. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01059-8 · Cited by 34
Gong, M., Yuan, M., Meng, L., Zhang, Z., Tse, G., Zhao, Y., Zhang, Y., Yuan, M., Liang, X., Fan, G., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2468031 · Cited by 33
Parcha, V., Patel, N., Kalra, R., Kim, J.-S., Gutiérrez, O. M., Arora, G., & Arora, P. K. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14690 · Cited by 33
Bogossian, H., Frommeyer, G., Brachmann, J., Lewalter, T., Hoffmann, E., Kuck, K. H., Andresen, D., Willems, S., Spitzer, S. G., Deneke, T., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.069 · Cited by 32
Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose
Ayhan, S., Öztürk, S., Alçelik, A., Özlü, M. F., Erdem, A., Memioğlu, T., Özdemir, M., & Yazıcı, M. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9722-1 · Cited by 31
Scirica, B. M. (2013) · Circulation · doi:10.1161/circulationaha.113.001180 · Cited by 29
Use of non‐vitamin K oral anticoagulants in people with atrial fibrillation and diabetes mellitus
Zadok, O. I. B., & Eisen, A. (2018) · Diabetic Medicine · doi:10.1111/dme.13600 · Cited by 28
Etiology, Pathology, and Classification of Atrial Fibrillation
Nayak, S., Natarajan, B., & Pai, R. G. (2020) · International Journal of Angiology · doi:10.1055/s-0040-1705153 · Cited by 23
Diabetes Mellitus Reduces the Antiarrhythmic Effect of Ion Channel Blockers
Ito, I., Hayashi, Y., Kawai, Y., Iwasaki, M., Takada, K., Kamibayashi, T., Yamatodani, A., & Mashimo, T. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000229709.29185.88 · Cited by 17
Soran, H., Banerjee, M., Mohamad, J. B., Adam, S., Ho, J. H., Ismaeel, S. M., Dhage, S. S., Syed, A. A., Abdulla, I. M. A., Younis, N., et al. (2018) · BioMed Research International · doi:10.1155/2018/5936180 · Cited by 16
Incidence and Risk Assessment for Atrial Fibrillation at 5 Years: Hypertensive Diabetic Cohort
Múria-Subirats, E., Clua‐Espuny, J. L., Ballesta-Ors, J., Lorman-Carbó, B., Lechuga-Durán, Í., Fernández‐Sáez, J., Pla-Farnós, R., & on behalf members of AFRICAT Group (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103491 · Cited by 15
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Zelniker, T. A., Bonaca, M. P., Furtado, R. H. M., Mosenzon, O., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044183 · Cited by 459
Epidemiology and modifiable risk factors for atrial fibrillation
Elliott, A. D., Middeldorp, M. E., Van Gelder, I. C., Albert, C. M., & Sanders, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00820-8 · Cited by 368
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74
Self-citation
Metadata
- Authors
- Wang, A., Green, J. B., Halperin, J. L., & Piccini, J. P.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2019-08
- Volume
- 74
- Issue
- 8
- Pages
- 1107-1115
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2969786006
- Cited by
- 400
- References
- 79
- FWCI
- 25.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.